CV · CapsoVision, Inc · Metrics
$6.37
+0.01 (+0.16%)
At close · Sep 9
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company, having evaluated the extant facts and circumstances, concluded that the facts and circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of issuance of these financial statements. While the Company raised approximately $14 million in gross proceeds resulting from the Private Placement described in Note 1. DESCRIPTION OF BUSINESS AND ORGANIZATIONAL STRUCTURE and further discussed in Note 9. COMMON STOCK, it is not probable that these funds are sufficient to fund expenditures necessary to achieve sales growth and innovation objectives. The Company intends to consummate additional capital raising activities, but there is no certainty as to such capital raising activities occurring at all, or occurring with sufficient timing or magnitude, sufficient to alleviate such substantial doubt.”View the 10-Q filed Aug 13, 2026
Market Cap
$318.30M
Shares
50.05M
CV metrics
64 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$6.37
Market cap
$318.30M
Price action
20 metricsPrice change (1W)
+8.3%
Price change (30D)
-4.8%
Price change (3M)
-15.1%
Price change (6M)
+22.5%
Price change (YTD)
-40.5%
Price change (1Y)
+74.7%
Trailing year
Price change (5Y)
—
52-week high
$14.42
52-week low
$3.56
Change from 52-week high
-55.9%
Change from 52-week low
+78.7%
Annualized volatility
98.2%
Annualized volatility (3M)
67.5%
Beta
0.9
RSI (14D)
53.6
Price vs SMA 50
-1.6%
Price vs SMA 200
-6.4%
Avg volume (3M)
144,210
Relative volume
2.7
Average dollar volume
$973,684
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
50.05M
Valuation
12 metricsP / E (TTM)
2.0
Trailing earnings · reciprocal yield 50.0%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
22.9×
reciprocal yield 4.4%
P / book
24.2
reciprocal yield 4.1%
FCF yield
-8.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-13
Profitability
9 metricsGross margin
50.9%
Operating margin
-217.1%
Trailing 12 months
Net margin
-214.7%
Gross profit (TTM)
$7.07M
Operating profit (TTM)
−$30.16M
Net income (TTM)
−$29.83M
Trailing 12 months
Diluted EPS (TTM)
$3.18
FCF margin
-200.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+9.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$13.89M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2,078.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-226.6%
Return on assets
-160.6%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
−$29.93M
Free cash flow (TTM)
−$27.89M
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
$18.57M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$27.82M
Capital expenditures (TTM)
$68,000
R&D (TTM)
$21.55M
SG&A (TTM)
—
Stock compensation (TTM)
$1.42M
R&D / revenue
155.2%
Stock compensation / revenue
10.2%
Ownership (13F)
3 metrics13F filers
50
13F filer change QoQ
-1
Institutional ownership
10.2%
Short interest
3 metricsShort interest
3.6%
Latest settlement · 17.1 days to cover
Days to cover
17.1d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
$1.01M
Insider-sentiment score
87 / 100
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
1378325
CUSIP
140935107
13F (30d)
33 filings
33 filers
Visit website
Investor relations